UPDATED Apr 25, 2024
Discover large cap U.S. Pharmaceuticals & Biotech companies that are on the NYSE and NASDAQ. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
WAT | US$308.35 | 4.8% | 3.4% | US$18.3b | US$325.36 | PE28.5x | E6.2% | n/a | ||
ALNY | US$143.71 | -1.0% | -26.7% | US$18.2b | US$220.00 | PS9.9x | E60.6% | n/a | ||
AVTR | US$25.15 | 3.5% | 34.2% | US$17.1b | US$27.85 | PE53.2x | E27.2% | n/a | ||
RPRX | US$28.11 | 0.8% | -20.5% | US$16.8b | US$45.40 | PE11.1x | E6.0% | 3.0% | ||
BMRN | US$82.17 | -8.8% | -11.1% | US$15.6b | US$109.74 | PE75.9x | E29.8% | n/a | ||
BGNE | US$148.56 | 12.6% | -41.9% | US$15.5b | US$268.26 | PS6.3x | E56.1% | n/a | ||
TEVA | US$13.25 | 3.7% | 55.5% | US$15.0b | US$15.74 | PB2x | E32.1% | 0% | ||
NBIX | US$137.76 | 3.9% | 35.2% | US$13.9b | US$153.63 | PE55.5x | E26.9% | n/a | ||
VTRS | US$11.47 | 3.1% | 23.9% | US$13.6b | US$12.40 | PE249x | E16.0% | 4.2% | ||
RVTY | US$102.09 | 2.7% | -20.6% | US$12.6b | US$123.24 | PE70.3x | E23.9% | 0.3% | ||
KRTX | US$329.83 | 3.3% | 80.7% | US$12.6b | US$326.92 | PS19238.9x | E60.1% | n/a | ||
MEDP | US$389.77 | 4.1% | 97.3% | US$12.0b | US$425.47 | PE38.6x | E13.8% | n/a | ||
SRPT | US$127.39 | 9.3% | 4.3% | US$12.0b | US$164.54 | PS9.7x | E42.6% | n/a | ||
BRKR | US$80.59 | 2.6% | 3.0% | US$11.7b | US$89.40 | PE27.4x | E2.5% | 0.2% | ||
CRL | US$227.81 | 0.1% | 24.0% | US$11.7b | US$270.67 | PE24.6x | E11.4% | n/a | ||
INCY | US$51.18 | -3.1% | -30.5% | US$11.5b | US$75.20 | PE19.2x | E18.8% | n/a | ||
NTRA | US$91.28 | 4.6% | 81.7% | US$11.2b | US$103.12 | PS10.3x | E68.7% | n/a | ||
UTHR | US$235.95 | -0.4% | 3.6% | US$11.1b | US$285.49 | PE11.3x | E7.6% | n/a | ||
EXAS | US$58.79 | -7.4% | -7.3% | US$10.7b | US$89.37 | PS4.3x | E61.9% | n/a | ||
CTLT | US$55.80 | 0% | 18.8% | US$10.1b | US$63.50 | PS2.5x | E92.2% | n/a | ||
TECH | US$62.66 | 0.7% | -19.4% | US$9.8b | US$80.43 | PE43.9x | E10.2% | 0.5% | ||
RGEN | US$165.66 | 5.5% | 14.1% | US$9.3b | US$210.88 | PE222.5x | E37.3% | n/a | ||
QGEN | US$41.08 | 4.1% | -9.9% | US$9.1b | US$50.75 | PE26.6x | E11.3% | n/a | ||
ROIV | US$10.88 | 5.0% | 29.1% | US$8.8b | US$16.08 | PE2x | E-54.3% | n/a |